Trials / Sponsors / Avexima Diol LLC
Avexima Diol LLC
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxapari Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Venous Thromboembolism (VTE) | Phase 3 | 2024-07-22 |
| Completed | Dimolegin® (60 mg) for Patients With Moderate COVID-19: A Non-Interventional Study COVID-19 | — | 2024-06-07 |